Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.


TSXV:RX - Post by User

Bullboard Posts
Comment by kingposton Sep 11, 2014 3:13pm
221 Views
Post# 22928091

RE:RE:Might Make Sense...

RE:RE:Might Make Sense...IMO you do not want to trade this stock, with lightly traded stocks they always drop a certain amount when you sell and go up when you buy..this probably would add up to 6 or 7% including selling and re-buying, and then add your commisions, the risk of missing a bump up... and unless for some reason you have decided to permantly exit (need cash etc) I would just sit tight and stay long.. I would not be surprised if we are at $15 by next earning report.... and yes ride out the volatility,,,,if it drops .50 or even a buck stay calm ...the best way to not get  nervous and over reative to volatility is to study the companies business fundamentals and know what they are doing and think about what where they will be a year out... JMO but the business model and management here is like no other I have ever seen, and expect things to continue for at least 3 or 4 years as they are now and then maybe bought out... I think they might accelerate their growth by increasing the number of aquisition rather than increasing the size... BTW... I can not give details but I know of an opportuntiy , totally off radar , so far, of three products that would be perfect for RX, and could all together bring at least $50 million in sales.. and let me just say I am not unconnected to these products....
Bullboard Posts